Study of the effect of Baricitinib on the Course of COVID-19
Alina Yuryevna Maslova, Alla Aslanbekovna Tskaeva, Zuleykha Abdulkerimkizi Ashurova, AlinaTemrukovna Abazova, Magomed Muradovich Ismailov, Maryam Muradovna Ismailova, Igor Spartakovich Baklanov, Artem Evgenevich Mishvelov, Sergey Nikolaevich Povetkin & Olga Aleksandrovna Baklanova · Journal of Pharmaceutical Research International · 2021
The aim of the study was to determine the effect of the inhibitor of janus kinase – baricitinib ("Olumiant") on the course of COVID-19. This drug baricitinib is able to suppress the systemic inflammatory response, which is one of the common causes of death in COVID-19, is an urge...